Latest News

  • Fragmentation Approach to Finding Remnants of Cancer in the Blood

    Diagnostics World | Molecular testing for minimal residual disease (MRD) is increasingly being used to detect cancer recurrence, and to that end many companies are actively developing assays. The tumor-informed approach based on the genetic mutations of patients has been particularly popular and often employs cell-free DNA (cfDNA) and more specifically circulating tumor DNA (ctDNA) analysis.

    Jul 9, 2025

  • Blood Test Detects Cancer with 95% Accuracy Using Microbiome RNA

    Diagnostics World | Researchers at the University of Chicago have published a new approach to cancer detection offering early unprecedented accuracy in identifying both early and late-stage cancers through a simple blood plasma test. The results were published today in a Brief Communication in Nature Biotechnology

    Jul 8, 2025

  • Digital Pathology’s Flywheel Effect: Growing Momentum, Growing Opportunity

    Diagnostics World | For patients who suffer negative health consequences from a delayed diagnosis, new-to-the-scene digital microfluidics (DMF) technology for multifunctional testing can literally save lives. A standout in the field is Baebies (Durham, North Carolina), which has developed a pair of such platforms cleared by the U.S. Food and Drug Administration (FDA) intended for rapid point-of-care testing to aid diagnostic testing in newborns.

    Jul 3, 2025

  • Digital Microfluidics Expanding the Value of Syndromic Testing

    Diagnostics World | For patients who suffer negative health consequences from a delayed diagnosis, new-to-the-scene digital microfluidics (DMF) technology for multifunctional testing can literally save lives. A standout in the field is Baebies (Durham, North Carolina), which has developed a pair of such platforms cleared by the U.S. Food and Drug Administration (FDA) intended for rapid point-of-care testing to aid diagnostic testing in newborns.

    Jul 1, 2025

  • Galatea Bio, Fabric Genomics Combine Pathogenic Variant Analysis with Polygenic Risk Score

    Diagnostics World | Galatea Bio and Fabric Genomics announced a strategic collaboration this week to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.

    Jun 26, 2025

  • Follow the Money: Neuroplastogens Novel Therapies, Genetic Medicines, More

    Diagnostics World | Elkedonia SAS plans to develop the drug-like small molecule inhibitors of Elk1, a novel intracellular target that plays a pivotal role in reward brain circuits and neuroplasticity; SpliceBio will advance the clinical development of their lead gene therapy candidate, SB-007, for Stargardt disease; and more.

    Jun 25, 2025

  • Veeva, Sarah Cannon Research Institute Collaboration, City of Hope Receives Grant, More

    Diagnostics World | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more.

    Jun 24, 2025

  • Nanoneedle Technology Could Transform Medical Diagnostics

    Diagnostics World | Researchers at King's College London have developed a diagnostic tool that could enable doctors to sample tissue during critical medical procedures. The nanoneedle patch technology enables physicians to extract molecular information from living tissue without causing damage or killing cells—a capability that could prove especially valuable in delicate surgical situations.

    Jun 20, 2025